Successful drug treatment of immune reconstitution disease with the leukotriene receptor antagonist, montelukast: a clue to pathogenesis?
Lipman
Marc C I
MC
Carding
Sally K
SK
D000085:Acetates / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D003521:Cyclopropanes; D015658:HIV Infections / Q000188:drug therapy; D006801:Humans; D007154:Immune System Diseases / Q000188:drug therapy*; D020024:Leukotriene Antagonists / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011804:Quinolines / Q000627:therapeutic use*; D013440:Sulfides; D013577:Syndrome
D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast